Production processes




Production processes

LLC Aziya immunopreparat has started producing bacteriophages, which are an effective alternative to antibiotics in the treatment of human infectious diseases. To date, LLC Aziya immunopreparat produces:

Bacteriophage cocktail:

✅ Bacteriophage Staphylococcal liquid MediPhag – a mix of sterile lysate phages against; Staphylococcus aureus.

✅ Bacteriophage Dysenteric Polyvalent MediPhag – a mix of sterile lysate phages against; Shigella flexeneri of 1, 2, 3, 6 serovariants and Shigella sonnei.

✅ Bacteriophage Salmonella Polyvalent MediPhag – a sterile filtrate of phagolysates active against Salmonellosis pathogens S. typhimurium, S. paratyphi B, S. newport, S. enteritidis, S. moscow, S. agama and S. java.

✅ GastroFag polyvalent MediPhag – a sterile purified filtrate of phagolysates of bacteria, S. typhimurium, S. paratyphi B, S. newport, S. enteritidis, S. moscow, S. agama, S. java, Shigella flexeneri of 1, 2, 3, 6 serovariants, Shigella sonnei, Shigella boydii, Proteus, Staphylococcus aureus, Pseudomonas aeruginisa and Escherichia coli.

Bacteriophage spray:

✅ Bacteriophage Staphylococcus spray MediPhag – a mix of sterile lysate phages against; Staphylococcus aureus.

Bacteriophage capsule:

✅ Bacteriophage Dysenteric Polyvalent MediPhag – a white gelatin capsule containing lyophilizied dried bacteriophage capsules against; Shigella flexeneri of 1, 2, 3, 6 serovariants and Shigella sonnei.

✅ Bacteriophage Salmonella Polyvalent MediPhag – a white gelatin capsule containing lyophilizied dried bacteriophage capsules against; S. typhimurium, S. paratyphi B, S. newport, S. enteritidis, S. moscow, S. agama and S. java.

✅ GastroFag polyvalent MediPhag – a white gelatin capsule containing lyophilizied dried bacteriophage capsules against; S. typhimurium, S. paratyphi B, S. newport, S. enteritidis, S. moscow, S. agama, S. java, Shigella flexeneri of 1, 2, 3, 6 serovariants, Shigella sonnei, Shigella boydii, Proteus, Staphylococcus aureus, Pseudomonas aeruginisa and Escherichia coli the most significant in the etiology of enteral diseases.

Bacteriophages, which literally means "bacteria eaters", are special viruses that can multiply only in the presence of a certain type of pathogenic bacteria. Bacteriophages are used for the prevention and treatment of many bacterial diseases. In medicine, bacteriophages are used to treat surgical, urogenital infections, gastroenterological diseases and bacterial infections of the upper respiratory tract. Because of their harmlessness, they are recommended to be used for the prevention and treatment of bacterial infections in pregnant women, during lactation, newborns and even premature babies, when the appointment of antibiotics is undesirable. What are the advantages of bacteriophages over antibiotics?

-Bacteriophages are highly specific in the treatment of infection, does not suppress the normal intestinal microflora and does not lead to dysbiosis.
-They have no contraindications to use: they can be prescribed to pregnant, nursing mothers and children of any age, including premature babies without the risk of complications to the liver, kidneys and other vital organs exposed to the damaging effects of conventional antibacterial agents
-They have a stimulating effect on the immune system.
-Does not have a toxic and allergic effect.
-They can be used in combination with other drugs, including antibiotics. One of the most important advantages of our bacteriophages is that they are obtained against a wide range of bacteria, including bacteria most commonly found in the Republic of Uzbekistan, and significant in the etiology of purulent-inflammatory, gastrointestinal infectious diseases. All our drugs are registered in the Republic of Uzbekistan and have quality certificates. The race of bacteriophages used in production are registered and deposited in the National Collection of Human Infection, Research Institute of Epidemiology, Microbiology and Infectious Diseases of the Ministry of Health of the Republic of Uzbekistan.

Address

Uzbekistan, Tashkent, Yunusabad district, 17th quarter, Industrial zone, Northern part of section No.2


Contacts

+99890 175-46-16
+99895 170-46-16
Email:info@mediphag.uz

About us
    LLC "Aziya immunopreparat" was established in 2014. Has a license for pharmaceutical activity No. P5073. The main activities of LLC "Aziya immunopreparat" are the development, production and sale of immunobiological drugs, in particular bacteriophages.